AKAN
Akanda Corp.
$10.16
-1.26 (-11.03%)
At close · Jul 8
Market Cap
$5.49M
Shares
540,841
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$10.16
Open$11.42
Day$10.11–11.42
52W$2.30–209.23
Avg vol 30d246K
Short int140K · 25.9% float · 1.0d
Short vol31%
DataMar 2022–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Sell
Momentum
Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−52%
below
Price vs 50-day avg
−51%
below
RSI (14)
34
neutral
MACD trend
Negative
52-week position
4%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−31%
trailing
6-month return
+14%
trailing
YTD return
−1%
this year
Relative strength
+7%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $21 › 200d $21 — 200d above 50d
Institutional flow
Accumulating
+500% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
25.86% of float · ▲ +84.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — 13F breadth
Squeeze score
49
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
290%
annualized · 1-yr
Max drawdown
−98%
past year
ATR
25.2%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−52%
Bearish
Price vs 50-day avg
−51%
Bearish
RSI (14)
34
Neutral
MACD trend
Negative
Bearish
52-week position
4%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $21 › 200d $21 — 200d above 50d
Institutional flow
Accumulating
+500% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
25.86% of float · ▲ +84.5% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $2
Now $10 · 4%
52-wk high $209
vs 200-day avg -52%
vs 50-day avg -51%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AKAN
this stock
Akanda Corp.
|
$5.49M | -1.3% | — | — | 25.9% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$53.49B | +7.4% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$51.02B | +4.9% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$42.94B | -3.6% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Accumulating
Holders
6
- % held
- 8.5%
- Net QoQ
- +46.1K sh
- Top holder
- CONTINUUM WEALTH ADVISORS…
Held
Float
Short & Settlement
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AKAN | -25.9% | -30.7% | +14.5% | -25.9% | -1.3% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -25.7% | -31.5% | +7.1% | -25.7% | -10.6% |